Carregant...
Statistical considerations for pediatric multidrug–resistant tuberculosis efficacy trials
Inclusion of newly licensed or repurposed drugs in regimens to treat children for multidrug–resistant–tuberculosis may lead to therapy that is shorter than traditional regimens and composed only of oral medications. As an all–oral regimen may be more acceptable and have a better safety profile than...
Guardat en:
| Publicat a: | Int J Tuberc Lung Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6086568/ https://ncbi.nlm.nih.gov/pubmed/29665951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.17.0358 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|